Friends and foes of international cooperation puzzle about how to explain order, stability, and predictability in a world without a central authority. How is the world governed in the absence of a world government? This probing yet accessible book examines "global governance" or…
Friends and foes of international cooperation puzzle about how to explain order, stability, and predictability in a world without a central authority. How is the world governed in the absence of a world government? This probing yet accessible book examines "global governance" or…
"Friends and foes of international cooperation puzzle about how to explain order, stability, and predictability in a world without a central authority"--Back cover.
"Friends and foes of international cooperation puzzle about how to explain order, stability, and predictability in a world without a central authority."--Page 4 of cover.
"Friends and foes of international cooperation puzzle about how to explain order, stability, and predictability in a world without a central authority."--Page 4 of cover.
A very high portion of the seafood we eat comes from abroad, mainly from China and Southeast Asia, and most of the active ingredients in medicines we take originate in other countries. Many low- and middle-income countries have lower labor costs and fewer and less stringent envi…
Reflections on Human Development explores a new development paradigm whose central focus is human well-being. Increases in income are treated as essential means, but not as the end of development - and not as the sum total of human life. The book discusses development policies a…
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by National Center for Biotechnology Information (É.-U.), Nicholson, Anna, English, Rebecca A., Guenther, Rita S., Claiborne, Anne B., Institute of Medicine (États-Unis)., Forum on Drug Discovery, Development, and Translation
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Nicholson, Anna, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.)), Institute of Medicine (U.S.)
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Nicholson, Anna, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, (2012, Washington, D.C.)
Logistics, Supply, and Demand -- Financing of MDR TB SLDs -- Innovative Suggestions and Potential Solutions. To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an un…
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.))
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …
Developing and strengthening the global supply chain for second-line drugs for multidrug-resistant tuberculos…: workshop summary
by Institute of Medicine (U.S.)., Board on Health Sciences Policy, Nicholson, Anna, Institute of Medicine (U.S.)., Forum on Drug Discovery, Development, and Translation, Workshop on Developing and Strengthening the Global Supply Chain for Second-Line Drugs for Multidrug-Resistant TB, Washington, D.C.))
To effectively treat patients diagnosed with drug-resistant (DR) tuberculosis (TB) and protect the population from further transmission of this infectious disease, an uninterrupted supply of quality-assured (QA), second-line anti-TB drugs (SLDs) is necessary. Patients diagnosed …